Tubulis
Ingo Lehrke is the CBO at Tubulis. Previously, Ingo was Managing Director at tesa Labtec Gmbh.
Ingo earned his Ph.D. in Pharmacology from Heidelberg University in 2000.
This person is not in any offices
Tubulis
2 followers
Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Their goal is to expand the therapeutic potential of antibody-drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. They will advance a range of conjugates, unlimited by indication, using their own discovery capabilities and by solving development challenges for partners with both antibody and chemical assets.